碳青霉烯类耐药肠杆菌科细菌临床检测与治疗方案的发展及应用  

Development and application of clinical determination and treatment for carbapenem-resistant Enterobacteriaceae

作　　者：王粟 赵虎 WANG Su;ZHAO Hu(Department of Clinical Laboratory,Huadong Hospital,Fudan University,Shanghai 200040,China)

机构地区：[1]复旦大学附属华东医院检验科,上海200040

出　　处：《检验医学》2020年第10期967-970,M0004,共5页Laboratory Medicine

摘　　要：随着广谱抗菌药物的超负荷应用,以碳青霉烯类耐药肠杆菌科细菌(CRE)为代表的多重耐药菌快速播散,成为临床抗感染治疗的巨大挑战。“碳青霉烯类耐药肠杆菌科细菌临床检测与治疗方案的发展及应用”专题汇集了CRE相关热点的4篇论著和2篇综述,分别阐述了CRE不同的检测方法和治疗策略,为临床CRE的诊疗和防控了提供重要的参考依据。With the overload use of broad-spectrum antibacterial drugs,multi-drug resistant bacteria,represented by carbapenem-resistant Enterobacteriaceae(CRE),have been rapidly spread,which has greatly threaten clinical anti-infection treatment.In this issue"The development and application of clinical determination and treatment for carbapenem-resistant Enterobacteriaceae",4 original articles and 2 reviews introduce different determination techniques and treatment strategies of CRE,which provides a reference for clinical diagnosis,treatment and prevention of CRE.

关 键 词：碳青霉烯类 肠杆菌科 耐药 检测 治疗 

分 类 号：R446.5[医药卫生—诊断学]